<DOC>
	<DOC>NCT00127192</DOC>
	<brief_summary>The purpose of this trial is to determine the efficacy and safety of an investigational drug in patients with type 2 diabetes mellitus.</brief_summary>
	<brief_title>A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patients with type 2 diabetes mellitus Patients with type 1 diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>